Navigation Links
B. Braun Obtains Permanent Injunction

BETHLEHEM, Pa., May 4, 2011 /PRNewswire/ -- Germany-based medical device manufacturer B. Braun Melsungen AG and its U.S. subsidiary B. Braun Medical Inc. (B. Braun) announced today that the company succeeded in obtaining a permanent injunction in its patent infringement case against Japan's Terumo Corporation and its U.S. subsidiary Terumo Medical Corporation.


On April 21, 2011, the U.S. District Court for the District of Delaware granted an immediate and permanent order, stopping Japan's Terumo Corporation and its U.S. subsidiary Terumo Medical Corporation from selling, or offering to sell, the Surshield® Safety IV Catheter in the acute care market, and precluding Terumo from bidding against B. Braun on expiring GPO contracts. Terumo will be permitted to continue selling the Surshield Safety IV Catheter into the alternative care market until June 1, 2012 after which it cannot make, sell, use or offer the Surshield Safety Catheter in the U.S.  B. Braun will seek damages and other relief for Terumo's infringement.

B. Braun's win follows a previous verdict awarded in November 2010, confirming the validity of an infringed claim of B. Braun's 2007 patent (U.S. Patent 7,264,613) for its Introcan Safety® IV Catheter.

About B. Braun's Introcan Safety® IV Catheter

B. Braun's Introcan Safety® IV Catheter, a passive, fully automatic safety device, designed to help protect against accidental needlestick injuries (NSIs). NSIs and other sharps injuries expose hundreds of thousands of healthcare providers each year to serious blood borne pathogens like hepatitis C and HIV. With the Introcan Safety® IV Catheter, the safety device is activated automatically and cannot be bypassed.

A recent landmark study conducted by GERES (Groupe d'Etude sur le Risque d'Exposition des Soignants) of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices like B. Braun's Introcan Safety® IV Catheter offer significantly better protection against NSIs than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.

For more information about B. Braun's Introcan Safety® IV Catheter visit  

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy,

B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, email us at or visit B. Braun at

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Offers Wound Patients a New Over-the-Counter Wound Management Gel - Prontosan®
2. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
3. B. Braun Wins Third Consecutive Safety IV Catheters Contract Award from Premier, Inc.
4. FDA-Approved Cefepime Now Available for Use in B. Brauns DUPLEX® System
5. B. Braun Customers Gain Premier Access to Zynx Health Device Networks Evidence-based, Customizable Drug Library Program
6. B. Braun Large Volume Heparin Infusion Solutions Now Available
7. New Technology Center Increases B. Brauns Infusion Pump Capacity
8. Health Robotics Re-Acquires CytoCares European Rights from B. Braun Melsungen AG for Undisclosed Consideration
9. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
10. B. Braun Renal Therapies Division Announces Availability of Adimea
11. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
Post Your Comments:
(Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda SyMRI ... (MR-bilder) för patienter med multipel skleros ... forskningsavtal med SyntheticMR AB för att kunna ... på sjukhuset. Med SyMRI kan man generera ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his ... is one of Joplin's most famous and beautiful concert posters. The concert was held ... Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom ...
(Date:11/26/2015)... NV (PRWEB) , ... November 26, 2015 , ... Inevitably ... strategy. Many customers choose to buy during the Black Friday and Cyber Monday ... Shoppers don’t need to search the Internet high and low to find the best ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare ... participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was ... November 8th through Wednesday, November 11th, 2015. The conference was held at the ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor ... application server to improve system efficiency and reliability. , The new Q-Suite 6 platform ... standards, the system avoids locking itself into a specific piece of software for many ...
Breaking Medicine News(10 mins):